Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
CYRX
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Jerrell Shelton Executive Vice President and Chief Financial Officer - Robert Stefanovich Chief Scientific Officer - Mark S…
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Jerrell SheltonExecutive Vice President and Chief Financial Officer - Robert StefanovichChief Scientific Officer - Mark Saw…
Cryoport affirms $192M-$196M 2026 revenue guidance while targeting continued adjusted EBITDA expansion
Earnings Call Insights: Cryoport, Inc. (CYRX) Q2 2026 MANAGEMENT VIEW * "We're pleased to report that our revenue momentum over the past several periods continued into the second quarter, with our total revenue reaching $49 million," said…
CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.2 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it…
Cryoport projects $192M-$196M FY 2026 revenue and expects positive adjusted EBITDA in 2H 2026
Earnings Call Insights: Cryoport, Inc. (CYRX) Q1 2026 MANAGEMENT VIEW * “Our first quarter results continue to demonstrate our market-leading position as revenue was $47.8 million, up 16% year-over-year,” said Jerrell Shelton (Chairman, Pr…
Cryoport, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Performance Drivers Revenue growth of 16% was driven by a 26% surge in commercial cell and gene therapy support and an 18% increase in clinical trial revenue, reflecting Cryopor…
Image source: The Motley Fool. DATE Tuesday, August 5, 2025 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Jerrell W. Shelton Chief Financial Officer — Robert S. Stefanovich Chief Scientific Officer — Mark W. Sawicki Vice Preside…
Image source: The Motley Fool. DATE Tuesday, Nov. 4, 2025 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Jerrell Shelton Chief Financial Officer — Robert Stefanovich Chief Scientific Officer — Mark W. Sawicki Vice President of Co…
Cryoport, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Performance Drivers Revenue growth was primarily driven by a 29% year-over-year increase in commercial cell and gene therapy support, which now represents 20% of total revenue.…
Earnings Call Insights: Cryoport, Inc. (CYRX) Q4 2025 MANAGEMENT VIEW * CEO Jerrell Shelton reported "full year revenue from continuing operations of $176.2 million, exceeding the high end of our prior guidance and reflecting continued mom…
Image source: The Motley Fool. DATE Tuesday, March 3, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Jerrell Shelton Chief Financial Officer — Robert Stefanovich Chief Scientific Officer — Dr. Mark Sawicki Vice President, Co…
Image source: The Motley Fool. DATE Tuesday, March 3, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Jerrell SheltonChief Financial Officer — Robert StefanovichChief Scientific Officer — Dr. Mark SawickiVice President, Corpo…
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.…
Cryoport Systems Wins 2025 BioTech Breakthrough Award For “BioServices Innovation of the Year”
LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the…
This article first appeared on GuruFocus. Release Date: November 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points CryoPort Inc (NASDAQ:CYRX) reported double-digit…
Cryoport updates 2025 revenue outlook to $170M-$174M while expanding global supply chain infrastructure
Earnings Call Insights: Cryoport, Inc. (CYRX) Q3 2025 MANAGEMENT VIEW * CEO Jerrell Shelton highlighted double-digit growth in both Life Sciences Services and Life Sciences Product segments, noting "revenue from our support of commercial c…
CryoPort (CYRX) Moves 7.0% Higher: Will This Strength Last?
CryoPort, Inc. (CYRX) shares ended the last trading session 7% higher at $10.71. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 12.9% gain over…
CryoPort (CYRX) Moves 7.0% Higher: Will This Strength Last?
CryoPort, Inc. (CYRX) shares ended the last trading session 7% higher at $10.71. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 12.9% gain over…
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] TOP GAINERS TICKER CHANGE COMMENT GO [https://www.chartmill.com/sto…
Apple, Astera Surge Among Market Cap Stock Movers on Wednesday
Wednesday’s trading session is witnessing notable fluctuations among stocks, with companies like Apple Computer Inc (NASDAQ:AAPL) and Astera Labs (ALAB) experiencing significant movements. In contrast, Adv Micro Device (NASDAQ:AMD) and Sna…
The market is filled with gapping stocks in Wednesday's session.
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps. [gap] GAP UP STOCKS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX/profile] 117.…
Discover the top movers in Wednesday's pre-market session.
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT SGBX [h…
Cryoport Q2 2025 slides: Revenue growth accelerates across all segments
Introduction & Market Context Cryoport Inc . (NASDAQ:CYRX), a provider of temperature-controlled supply chain solutions for the life sciences industry, presented its second quarter 2025 earnings on August 5, 2025. The company reported stro…
CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items. This…
Cryoport Inc earnings beat by $2.32, revenue topped estimates
Investing.com - Cryoport Inc (NASDAQ: CYRX) reported second quarter EPS of $2.05, $2.32 better than the analyst estimate of $-0.27. Revenue for the quarter came in at $45.5M versus the consensus estimate of $41.74M. Cryoport Inc’s stock pr…
Cryoport Reports Second Quarter 2025 Financial Results
Second quarter revenue increased 14% year-over-year to $45.5 million Commercial Cell & Gene Therapy revenue increased 33% year-over-year to $8.7 million Life Sciences Services revenue rose 21% year-over-year, including a 28% increase in Bi…
Hub Group (HUBG) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items. Thi…
DHL Group Sponsored ADR (DHLGY) Earnings Expected to Grow: Should You Buy?
The market expects DHL Group Sponsored ADR (DHLGY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing t…
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
CryoPort, Inc. (CYRX) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings…
EXCLUSIVE: Cryoport Boosts Cold Chain Tech With New Shippers Designed For Delays And Rough Handling
Cryoport (NASDAQ:CYRX) on Tuesday announced the launch of MVE Biological Solutions’ new vapor shippers, the SC 4/2V and SC 4/3V. The company said these shippers offer medical and animal health professionals, laboratories, researchers, hosp…
Cryoport CEO Jerrell Shelton sells $115k in shares
Cryoport, Inc. (NASDAQ:CYRX) President and CEO Jerrell Shelton sold 16,344 shares of common stock on June 24, 2025, at a weighted average price of $7.0586, for a total of $115,365. The transaction comes as the $365M market cap company’s st…
Insider Sale: President of $CYRX Sells 151,304 Shares
JERRELL SHELTON, the President of $CYRX, sold 151,304 shares of the company on 06-17-2025 for an estimated $1,029,714. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.2% of their shares of this c…
Cryoport CEO Jerrell Shelton sells $2.3 million in CYRX stock
Cryoport, Inc. (NASDAQ:CYRX), a $319 million market cap company, saw its President and CEO Jerrell Shelton sell a total of 339,720 shares of common stock between June 17 and June 20, 2025. The sales, executed under a pre-arranged trading p…
Cryoport director Ramkumar Mandalam sells $75,348 in stock
BRENTWOOD, TN—Ramkumar Mandalam, a director at Cryoport, Inc. (NASDAQ:CYRX), has sold a total of $75,348 worth of the company’s common stock, according to a recent SEC filing. The transactions occurred over three consecutive days, from Jun…
C.H. Robinson (CHRW) Surges 5.7%: Is This an Indication of Further Gains?
C.H. Robinson Worldwide (CHRW) shares ended the last trading session 5.7% higher at $91.94. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.3%…